Clinical Trial Update: Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 QTc study by Bristol-Myers Squibb in healthy subjects has been completed, with Alzheimer’s disease listed as the associated condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED